| 1 | 1.2 mg ZGN-440 for injectable suspension | - | - | - | - | [1] 193 193 💬
|
| 2 | 1.8 mg ZGN-440 for injectable suspension | - | - | - | - | [1] 193 193 💬
|
| 3 | [AZP-531] | - | - | - | - | [1] 193 193 💬
|
| 4 | [H01BB02] | - | - | - | - | [1] 193 193 💬
|
| 5 | [RGH-706] | - | - | - | - | [1] 193 193 💬
|
| 6 | Acetylcysteine | [1] Acetylcysteine Acetylcysteine | [1] Acetylcysteine
Acetylcysteine
💬
| - | - | [25] 2 2, 6, 13, 19, 20, 21, 34, 49, 51, 53, 58, 63, 85, 90, 94, 97, 111, 164, 193, 233, 296, 298, 299, 303, 337 💬
|
| 7 | ACOMPLIA 20 mg film-coated tablets | - | - | - | - | [1] 193 193 💬
|
| 8 | Acylated and unacylated ghrelin dosages | - | - | - | - | [3] 193 193, 201, 202 💬
|
| 9 | ANASTROZOLE | [1] Anastrozole Anastrozole | [1] Anastrozole
Anastrozole
💬
| [1] CYP19A1 CYP19A1 💬
| [2] Ovarian steroidogenesis Ovarian steroidogenesis, Steroid hormone biosynthesis 💬 | [3] 78 78, 86, 193 💬
|
| 10 | ARD-101 | - | - | - | - | [1] 193 193 💬
|
| 11 | AZP-531 | - | - | - | - | [1] 193 193 💬
|
| 12 | B. lactis B94 | - | - | - | - | [1] 193 193 💬
|
| 13 | Behavioral: Eating | - | - | - | - | [1] 193 193 💬
|
| 14 | Beloranib | [1] Beloranib Beloranib | - | - | - | [1] 193 193 💬
|
| 15 | Biopsy | - | - | - | - | [7] 28 28, 34, 51, 65, 97, 193, 285 💬
|
| 16 | Blood draw | - | - | - | - | [16] 3 3, 6, 13, 19, 46, 48, 49, 51, 58, 65, 67, 193, 215, 231, 298, 299 💬
|
| 17 | BMB-101 | - | - | - | - | [3] 140 140, 144, 193 💬
|
| 18 | Byetta | - | - | - | - | [2] 78 78, 193 💬
|
| 19 | Cannabidiol | [1] Cannabidiol Cannabidiol | [1] Cannabidiol
Cannabidiol
💬
| [2] CNR1 CNR1, CNR2 💬
| [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [20] 6 6, 8, 13, 19, 36, 46, 51, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬
|
| 20 | Cannabidiol Oral Solution | [1] Cannabidiol Cannabidiol | [1] Cannabidiol
Cannabidiol
💬
| [2] CNR1 CNR1, CNR2 💬
| [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [4] 140 140, 144, 145, 193 💬
|
| 21 | Carbetocin | [1] Carbetocin Carbetocin | [1] Carbetocin
Carbetocin
💬
| [1] OXTR OXTR 💬
| [5] Calcium signaling pathway Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬 | [1] 193 193 💬
|
| 22 | CBDV Compound | - | - | - | - | [1] 193 193 💬
|
| 23 | Choline | [1] Choline Choline | [1] Choline
Choline
💬
| - | - | [4] 93 93, 171, 193, 299 💬
|
| 24 | Coenzyme Q10 | - | - | - | - | [11] 2 2, 5, 6, 8, 10, 18, 49, 57, 107, 113, 193 💬
|
| 25 | CSTI-500 | - | - | - | - | [1] 193 193 💬
|
| 26 | D.3.2 Product code where applicable13: | - | - | - | - | [1] 193 193 💬
|
| 27 | DCCR | - | - | - | - | [1] 193 193 💬
|
| 28 | DCCR (Diazoxide Choline) Extended- Release Tablet | [2] Choline Choline, Diazoxide | [3] Diazoxide
Diazoxide
,
Choline
,
Diazoxide choline
💬
| [2] ABCC8 ABCC8, KCNJ11 💬
| [4] ABC transporters ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬 | [1] 193 193 💬
|
| 29 | DEXA, blood tests, H.G.P.O, osseous age. | - | - | - | - | [1] 193 193 💬
|
| 30 | Diazoxide | [1] Diazoxide Diazoxide | [2] Diazoxide
Diazoxide
,
Diazoxide choline
💬
| [2] ABCC8 ABCC8, KCNJ11 💬
| [4] ABC transporters ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬 | [2] 13 13, 193 💬
|
| 31 | DIAZOXIDE CHOLINE | [2] Choline Choline, Diazoxide | [3] Diazoxide
Diazoxide
,
Choline
,
Diazoxide choline
💬
| [2] ABCC8 ABCC8, KCNJ11 💬
| [4] ABC transporters ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬 | [1] 193 193 💬
|
| 32 | Diazoxide choline controlled-release tablet | [2] Choline Choline, Diazoxide | [3] Diazoxide
Diazoxide
,
Choline
,
Diazoxide choline
💬
| [2] ABCC8 ABCC8, KCNJ11 💬
| [4] ABC transporters ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬 | [1] 193 193 💬
|
| 33 | EU/1/06/362/003: 5µg (1 pen) | - | - | - | - | [1] 193 193 💬
|
| 34 | Eutropin | - | - | - | - | [1] 193 193 💬
|
| 35 | EXENATIDE | [1] Exenatide Exenatide | [1] Exenatide
Exenatide
💬
| [1] GLP1R GLP1R 💬
| [4] Hormone signaling Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [6] 6 6, 17, 72, 78, 193, 233 💬
|
| 36 | FE 992097 | - | - | - | - | [1] 193 193 💬
|
| 37 | Fluimucil | - | - | - | - | [1] 193 193 💬
|
| 38 | Fluimucil (acetylcysteine) | [1] Acetylcysteine Acetylcysteine | [1] Acetylcysteine
Acetylcysteine
💬
| - | - | [1] 193 193 💬
|
| 39 | Follow-up study of the treated cohort | - | - | - | - | [1] 193 193 💬
|
| 40 | GENOTONORM | - | - | - | - | [1] 193 193 💬
|
| 41 | Genotonorm Miniquick 0,2 mg | - | - | - | - | [1] 193 193 💬
|
| 42 | Genotropin | - | - | - | - | [6] 13 13, 77, 107, 187, 193, 222 💬
|
| 43 | GENOTROPIN (Somatropin) is a growth hormone treatment. It is an exact copy of the natural growth hormone that our bodies make. The main difference is that GENOTROPIN is man-made. | - | - | - | - | [1] 193 193 💬
|
| 44 | Genotropin GoQuick | - | - | - | - | [1] 193 193 💬
|
| 45 | GH treatment (Somatropin) | - | - | - | - | [1] 193 193 💬
|
| 46 | GLWL-01 | - | - | - | - | [1] 193 193 💬
|
| 47 | Gold | [1] Gold Gold | - | - | - | [71] 2 2, 5, 6, 11, 13, 17, 19, 21, 22, 28, 34, 35, 46, 49, 50, 53, 54, 56, 57, 58, 60, 63, 64, 65, 66, 68, 71, 75, 76, 77, 79, 84, 85, 86, 88, 91, 93, 95, 96, 97, 98, 107, 113, 127, 137, 158, 162, 167, 171, 193, 206, 215, 218, 222, 223, 224, 226, 227, 228, 230, 235, 271, 291, 294, 296, 298, 299, 310, 318, 331, 340 💬
|
| 48 | Growth Hormone | - | - | - | - | [10] 19 19, 46, 78, 96, 97, 107, 191, 193, 265, 299 💬
|
| 49 | Growth hormone (Genotonorm® or Omnitrope®) | - | - | - | - | [1] 193 193 💬
|
| 50 | Guanfacine | [1] Guanfacine Guanfacine | [2] Guanfacine hydrochloride
Guanfacine hydrochloride
,
Guanfacine
💬
| [1] ADRA2A ADRA2A 💬
| [4] Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 193 193 💬
|
| 51 | Guanfacine Extended Release | [1] Guanfacine Guanfacine | [2] Guanfacine hydrochloride
Guanfacine hydrochloride
,
Guanfacine
💬
| [1] ADRA2A ADRA2A 💬
| [4] Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 193 193 💬
|
| 52 | Guanfacine extended release (GXR) | [1] Guanfacine Guanfacine | [2] Guanfacine hydrochloride
Guanfacine hydrochloride
,
Guanfacine
💬
| [1] ADRA2A ADRA2A 💬
| [4] Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 193 193 💬
|
| 53 | H01BB02 | - | - | - | - | [1] 193 193 💬
|
| 54 | Humatrope 6 mg/12 mg/24 mg injektiokuiva-aine ja liuotin, liuosta varten | - | - | - | - | [1] 193 193 💬
|
| 55 | INN Not yet proposed | - | - | - | - | [1] 193 193 💬
|
| 56 | Intranasal oxytocin | [1] Oxytocin Oxytocin | [1] Oxytocin
Oxytocin
💬
| [1] OXTR OXTR 💬
| [5] Calcium signaling pathway Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬 | [2] 127 127, 193 💬
|
| 57 | Intranasal Oxytocin (IN-OXT) | [1] Oxytocin Oxytocin | [1] Oxytocin
Oxytocin
💬
| [1] OXTR OXTR 💬
| [5] Calcium signaling pathway Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬 | [1] 193 193 💬
|
| 58 | Liraglutide | [1] Liraglutide Liraglutide | [1] Liraglutide
Liraglutide
💬
| [1] GLP1R GLP1R 💬
| [4] Hormone signaling Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [5] 6 6, 13, 75, 77, 193 💬
|
| 59 | Livoletide | [1] Livoletide Livoletide | - | - | - | [1] 193 193 💬
|
| 60 | Medical air | [1] Medical air Medical air | [1] Air, medical
Air, medical
💬
| - | - | [3] 85 85, 86, 193 💬
|
| 61 | Medical Air vs Oxygen | [2] Medical air Medical air, Oxygen | [2] Oxygen
Oxygen
,
Air, medical
💬
| - | - | [1] 193 193 💬
|
| 62 | Metoprolol | [1] Metoprolol Metoprolol | [4] Metoprolol tartrate
Metoprolol tartrate
,
Metoprolol succinate
,
Metoprolol
,
Metoprolol fumarate
💬
| [1] ADRB1 ADRB1 💬
| [13] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [6] 17 17, 57, 58, 113, 193, 226 💬
|
| 63 | Metoprolol succinate | [1] Metoprolol Metoprolol | [4] Metoprolol tartrate
Metoprolol tartrate
,
Metoprolol succinate
,
Metoprolol
,
Metoprolol fumarate
💬
| [1] ADRB1 ADRB1 💬
| [13] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [4] 57 57, 58, 113, 193 💬
|
| 64 | METOPROLOL SUCCINATE (PH. EUR.) | [1] Metoprolol Metoprolol | [4] Metoprolol tartrate
Metoprolol tartrate
,
Metoprolol succinate
,
Metoprolol
,
Metoprolol fumarate
💬
| [1] ADRB1 ADRB1 💬
| [13] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 193 193 💬
|
| 65 | Metoprololsuccinat Orion 25mg | - | - | - | - | [1] 193 193 💬
|
| 66 | Metoprololsuccinat ”Orion” 25mg | - | - | - | - | [1] 193 193 💬
|
| 67 | METYRAPONE | [1] Metyrapone Metyrapone | [1] Metyrapone
Metyrapone
💬
| [1] CYP11B1 CYP11B1 💬
| [3] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Steroid hormone biosynthesis 💬 | [2] 75 75, 193 💬
|
| 68 | Muscle biopsy | - | - | - | - | [2] 193 193, 344 💬
|
| 69 | NBT-NM108 | - | - | - | - | [1] 193 193 💬
|
| 70 | NNZ-2591 | [1] NNZ-2591 NNZ-2591 | - | - | - | [2] 193 193, 201 💬
|
| 71 | Norditropin SimpleXx | - | - | - | - | [5] 3 3, 97, 107, 193, 195 💬
|
| 72 | Nutropin AQ | - | - | - | - | [4] 78 78, 134, 193, 299 💬
|
| 73 | Octreotide | [1] Octreotide Octreotide | [5] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
,
Octreotide hydrochloride
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [8] 67 67, 75, 77, 84, 85, 89, 193, 227 💬
|
| 74 | OMNITROPE | - | - | - | - | [1] 193 193 💬
|
| 75 | OSSITOCINA | - | - | - | - | [2] 127 127, 193 💬
|
| 76 | OT | - | - | - | - | [1] 193 193 💬
|
| 77 | Other: Blood Samples | - | - | - | - | [13] 3 3, 13, 46, 51, 53, 63, 85, 86, 88, 96, 98, 140, 193 💬
|
| 78 | Other: Control | - | - | - | - | [12] 6 6, 19, 67, 70, 75, 85, 96, 97, 162, 193, 226, 296 💬
|
| 79 | Other: exercise and blood tests | - | - | - | - | [1] 193 193 💬
|
| 80 | Other: Follow-up study of the untreated cohort | - | - | - | - | [1] 193 193 💬
|
| 81 | Other: Low dose (1 mcg) ACTH stimulation test | - | - | - | - | [1] 193 193 💬
|
| 82 | Other: Overnight metyrapone test | [1] Metyrapone Metyrapone | [1] Metyrapone
Metyrapone
💬
| [1] CYP11B1 CYP11B1 💬
| [3] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Steroid hormone biosynthesis 💬 | [1] 193 193 💬
|
| 83 | Oxygen | [1] Oxygen Oxygen | [1] Oxygen
Oxygen
💬
| - | - | [30] 6 6, 13, 15, 19, 22, 36, 46, 49, 70, 71, 85, 86, 88, 90, 96, 97, 129, 149, 168, 193, 211, 226, 230, 235, 269, 271, 294, 298, 299, 330 💬
|
| 84 | Oxytocin | [1] Oxytocin Oxytocin | [1] Oxytocin
Oxytocin
💬
| [1] OXTR OXTR 💬
| [5] Calcium signaling pathway Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬 | [8] 6 6, 70, 72, 127, 168, 193, 206, 226 💬
|
| 85 | Oxytocin (OXT) continuous | [1] Oxytocin Oxytocin | [1] Oxytocin
Oxytocin
💬
| [1] OXTR OXTR 💬
| [5] Calcium signaling pathway Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬 | [1] 193 193 💬
|
| 86 | Oxytocin nasal spray | [1] Oxytocin Oxytocin | [1] Oxytocin
Oxytocin
💬
| [1] OXTR OXTR 💬
| [5] Calcium signaling pathway Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬 | [3] 70 70, 72, 193 💬
|
| 87 | Part A: RM-718 | - | - | - | - | [1] 193 193 💬
|
| 88 | Part B: RM-718 | - | - | - | - | [1] 193 193 💬
|
| 89 | Part C: RM-718 | - | - | - | - | [1] 193 193 💬
|
| 90 | Part D: RM-718 | - | - | - | - | [1] 193 193 💬
|
| 91 | Physiological serum (Sodium chloride) | [1] Sodium chloride Sodium chloride | [1] Sodium chloride
Sodium chloride
💬
| - | - | [1] 193 193 💬
|
| 92 | Pitolisant | [1] Pitolisant Pitolisant | [2] Pitolisant
Pitolisant
,
Pitolisant hydrochloride
💬
| [1] HRH3 HRH3 💬
| [2] Neuroactive ligand signaling Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [3] 6 6, 113, 193 💬
|
| 93 | Pitolisant oral tablets | [1] Pitolisant Pitolisant | [2] Pitolisant
Pitolisant
,
Pitolisant hydrochloride
💬
| [1] HRH3 HRH3 💬
| [2] Neuroactive ligand signaling Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [1] 193 193 💬
|
| 94 | Pitolisant tablet | [1] Pitolisant Pitolisant | [2] Pitolisant
Pitolisant
,
Pitolisant hydrochloride
💬
| [1] HRH3 HRH3 💬
| [2] Neuroactive ligand signaling Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [1] 193 193 💬
|
| 95 | Prebiotics with galactomannan and oligofructose | - | - | - | - | [1] 193 193 💬
|
| 96 | Probiotic | - | - | - | - | [10] 2 2, 6, 13, 93, 96, 97, 127, 193, 266, 299 💬
|
| 97 | Probiotics including B. lactis B420, B. lactis HN019, B. animalis Bb-12, L. rhamnosus GG | - | - | - | - | [1] 193 193 💬
|
| 98 | R05CB01 | - | - | - | - | [1] 193 193 💬
|
| 99 | RAD011 | - | - | - | - | [1] 193 193 💬
|
| 100 | RECOMBINANT HUMAN GROWTH HORMON | - | - | - | - | [1] 193 193 💬
|
| 101 | Recombinant human growth hormone | - | - | - | - | [4] 77 77, 193, 265, 276 💬
|
| 102 | Recombinant Human Growth Hormone (rhGH) Injection | - | - | - | - | [1] 193 193 💬
|
| 103 | Recombinant Somatropin | - | - | - | - | [1] 193 193 💬
|
| 104 | RGH-706 | - | - | - | - | [1] 193 193 💬
|
| 105 | RGH-706 HYDROCHLORIDE | - | - | - | - | [1] 193 193 💬
|
| 106 | Rimonabant | [1] Rimonabant Rimonabant | [1] Rimonabant
Rimonabant
💬
| [1] CNR1 CNR1 💬
| [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 193 193 💬
|
| 107 | RM-493 | - | - | - | - | [2] 193 193, 202 💬
|
| 108 | Sandostatin LAR | - | - | - | - | [5] 67 67, 77, 84, 193, 227 💬
|
| 109 | Saxenda | - | - | - | - | [1] 193 193 💬
|
| 110 | Setmelanotide | [1] Setmelanotide Setmelanotide | [2] Setmelanotide
Setmelanotide
,
Setmelanotide acetate
💬
| [1] MC4R MC4R 💬
| [3] Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [5] 134 134, 193, 202, 236, 265 💬
|
| 111 | Sodium chloride | [1] Sodium chloride Sodium chloride | [1] Sodium chloride
Sodium chloride
💬
| - | - | [31] 2 2, 6, 11, 13, 14, 22, 34, 41, 46, 50, 51, 53, 60, 65, 67, 70, 85, 96, 97, 124, 168, 193, 214, 215, 226, 227, 228, 271, 288, 298, 299 💬
|
| 112 | Somatropin | - | - | - | - | [14] 3 3, 74, 75, 78, 97, 107, 113, 187, 193, 195, 222, 238, 274, 276 💬
|
| 113 | Somatropin - adult cohort | - | - | - | - | [1] 193 193 💬
|
| 114 | Somatropin - GH naïve pediatric cohort | - | - | - | - | [1] 193 193 💬
|
| 115 | Somatropin - GH treated cohort | - | - | - | - | [1] 193 193 💬
|
| 116 | SOMATROPIN FOR INJECTION | - | - | - | - | [1] 193 193 💬
|
| 117 | Subcutaneous Beloranib in Suspension | [1] Beloranib Beloranib | - | - | - | [1] 193 193 💬
|
| 118 | Syntocinon | - | - | - | - | [2] 127 127, 193 💬
|
| 119 | Syntocinon nasal spray | - | - | - | - | [1] 193 193 💬
|
| 120 | Syntocinon®/- Spray | - | - | - | - | [1] 193 193 💬
|
| 121 | Tesofensine | [1] Tesofensine Tesofensine | - | - | - | [2] 6 6, 193 💬
|
| 122 | TESOFENSINE CITRATE | [1] Tesofensine Tesofensine | - | - | - | [1] 193 193 💬
|
| 123 | Tesofensine/Metoprolol | [2] Metoprolol Metoprolol, Tesofensine | [4] Metoprolol tartrate
Metoprolol tartrate
,
Metoprolol succinate
,
Metoprolol
,
Metoprolol fumarate
💬
| [1] ADRB1 ADRB1 💬
| [13] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 193 193 💬
|
| 124 | Tesomet | - | - | - | - | [1] 193 193 💬
|
| 125 | Tirzepatide | [1] Tirzepatide Tirzepatide | [1] Tirzepatide
Tirzepatide
💬
| [2] GIPR GIPR, GLP1R 💬
| [4] Hormone signaling Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [6] 67 67, 96, 97, 193, 233, 265 💬
|
| 126 | TOPIRAMATE | [1] Topiramate Topiramate | [1] Topiramate
Topiramate
💬
| [37] CA2 CA2, CA4, CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| [55] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Arrhythmogenic right ventricular cardiomyopathy, Bile secretion, Cadherin signaling, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Huntington disease, Hypertrophic cardiomyopathy, IgSF CAM signaling, Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [6] 6 6, 97, 140, 144, 156, 193 💬
|
| 127 | VYKAT XR | - | - | - | - | [1] 193 193 💬
|
| 128 | ZGN-440 | - | - | - | - | [1] 193 193 💬
|
| 129 | ZGN-440 for Injectable Suspension | - | - | - | - | [1] 193 193 💬
|
| 130 | ZGN-440 sterile diluent | - | - | - | - | [1] 193 193 💬
|